Paul Elvin

Paul Elvin is an experienced professional in the field of translational medicine and science. Currently serving as the Director of Translational Medicine at PTEN Research since July 2019, Paul also contributes as a Consultant Translational Scientist at Oncognition from November 2015 to the present. Previously, from November 2015 to January 2023, Paul held the position of Chief Translational Science Officer at Aptus Clinical Ltd. Paul's extensive career began at AstraZeneca R&D, where Paul worked as a Principal Scientist for nearly 27 years, from October 1988 to November 2015.